This site is intended for Healthcare Professionals only.

Search here...

Tag: Amgen; lung cancer; sotorasib; KRAS G12C mutation; MHRA

spot_imgspot_img

Lung cancer patients in England will be first in Europe to receive Amgen’s ‘revolutionary’ drug

News PB Staff Writer PB Staff Writer -
Lung cancer patients in England will become the first in Europe to receive a drug made by a US biotech company that targets a specific gene mutation. NHS England will be fast-tracking Amgen's lung cancer drug sotorasib after it was shown in clinical trials to...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Breast Cancer survivors face heightened risk of second cancers, new research reveals

News 0
Higher risks of breast cancer and second primary cancers...

Have NHS ambulance response times improved? Lib Dems raise concern

News 0
The party sounds alarm over ambulance Category 2 delays...

Sigma Pharmaceuticals donates £20K to local charity Citizen Advice Watford

News 0
Sigma will continue to partner with the local charity...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.